BMNDF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
7.75M
PHGE
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Jul 30 closing price
Capitalization
10.68M
Interact to see
Advertisement

BMNDF vs PHGE

Header iconBMNDF vs PHGE Comparison
Open Charts BMNDF vs PHGEBanner chart's image
BIOMIND LABS
Price$0.10
Change-$0.00 (-0.00%)
Volume$4.02K
Capitalization7.75M
BiomX
Price$0.41
Change-$0.00 (-0.00%)
Volume$140.66K
Capitalization10.68M
BMNDF vs PHGE Comparison Chart in %
Loading...
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMNDF vs. PHGE commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMNDF is a Buy and PHGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (BMNDF: $0.10 vs. PHGE: $0.41)
Brand notoriety: BMNDF and PHGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMNDF: 143% vs. PHGE: 9%
Market capitalization -- BMNDF: $7.75M vs. PHGE: $10.68M
BMNDF [@Biotechnology] is valued at $7.75M. PHGE’s [@Biotechnology] market capitalization is $10.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMNDF’s FA Score shows that 0 FA rating(s) are green whilePHGE’s FA Score has 1 green FA rating(s).

  • BMNDF’s FA Score: 0 green, 5 red.
  • PHGE’s FA Score: 1 green, 4 red.
According to our system of comparison, PHGE is a better buy in the long-term than BMNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMNDF’s TA Score shows that 2 TA indicator(s) are bullish while PHGE’s TA Score has 6 bullish TA indicator(s).

  • BMNDF’s TA Score: 2 bullish, 2 bearish.
  • PHGE’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, PHGE is a better buy in the short-term than BMNDF.

Price Growth

BMNDF (@Biotechnology) experienced а 0.00% price change this week, while PHGE (@Biotechnology) price change was -5.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.29%. For the same industry, the average monthly price growth was +15.27%, and the average quarterly price growth was +40.33%.

Reported Earning Dates

PHGE is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (-2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHGE($10.7M) has a higher market cap than BMNDF($7.75M). PHGE YTD gains are higher at: -44.117 vs. BMNDF (-67.490). BMNDF has higher annual earnings (EBITDA): -314.15K vs. PHGE (-6.21M). PHGE has more cash in the bank: 20.1M vs. BMNDF (10.1K). BMNDF has less debt than PHGE: BMNDF (883K) vs PHGE (9.29M). BMNDF (0) and PHGE (0) have equivalent revenues.
BMNDFPHGEBMNDF / PHGE
Capitalization7.75M10.7M72%
EBITDA-314.15K-6.21M5%
Gain YTD-67.490-44.117153%
P/E RatioN/A0.02-
Revenue00-
Total Cash10.1K20.1M0%
Total Debt883K9.29M10%
FUNDAMENTALS RATINGS
BMNDF vs PHGE: Fundamental Ratings
BMNDF
PHGE
OUTLOOK RATING
1..100
3831
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9692
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHGE's Valuation (28) in the null industry is significantly better than the same rating for BMNDF (96). This means that PHGE’s stock grew significantly faster than BMNDF’s over the last 12 months.

BMNDF's Profit vs Risk Rating (93) in the null industry is in the same range as PHGE (100). This means that BMNDF’s stock grew similarly to PHGE’s over the last 12 months.

PHGE's SMR Rating (97) in the null industry is in the same range as BMNDF (100). This means that PHGE’s stock grew similarly to BMNDF’s over the last 12 months.

PHGE's Price Growth Rating (92) in the null industry is in the same range as BMNDF (96). This means that PHGE’s stock grew similarly to BMNDF’s over the last 12 months.

PHGE's P/E Growth Rating (82) in the null industry is in the same range as BMNDF (100). This means that PHGE’s stock grew similarly to BMNDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMNDFPHGE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
41%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
14%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KITT0.940.01
+1.47%
Nauticus Robotics Inc.
NOC572.81-0.41
-0.07%
Northrop Grumman Corp
SGHT3.45-0.01
-0.29%
Sight Sciences
JBSS64.94-1.80
-2.70%
John B Sanfilippo & Son
ALIT5.39-0.15
-2.71%
Alight

BMNDF and

Correlation & Price change

A.I.dvisor tells us that BMNDF and APM have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and APM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
APM - BMNDF
27%
Poorly correlated
+1.84%
LVTX - BMNDF
23%
Poorly correlated
-3.40%
PHGE - BMNDF
22%
Poorly correlated
-1.21%
CYDY - BMNDF
12%
Poorly correlated
+4.60%
CLVLY - BMNDF
1%
Poorly correlated
+2.39%
More